Avagimyan A, Sheibani M, Pogosova N, Mkrtchyan L, Yeranosyan H, Aznauryan A, Sahaakyan K, Fogacci F, Cicero A, Shafie D, Sarrafzadegan N, Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy, «INTERNATIONAL JOURNAL OF CARDIOLOGY», 2023, 391, Article number: 131331, pp. 1 - 9 [articolo]
Fogacci F, Rizzo M, Cicero AFG, PUFA treatment in patients with gestational diabetes mellitus: Lights and shadows, «JOURNAL OF DIABETES AND ITS COMPLICATIONS», 2023, 37, pp. 1 - 2 [articolo]Open Access
Cicero AFG, Fogacci F, Di Micoli V, Angeloni C, Giovannini M, Borghi C, Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2023, 24, Article number: 7027, pp. 1 - 14 [articolo]Open Access
Cicero AFG, Fogacci F, Stoian AP, Toth PP., Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review, «NUTRIENTS», 2023, 15, Article number: 2288, pp. 1 - 28 [articolo]Open Access
Cicero AFG, Fogacci F, D'Addato S, Grandi E, Rizzoli E, Borghi C, On Behalf Of The Brisighella Heart Study., Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study., «NUTRIENTS», 2023, 15, Article number: 312, pp. 1 - 10 [articolo]Open Access
Casiglia E, Tikhonoff V, Virdis A, Grassi G, Angeli F, Barbagallo CM, Bombelli M, Cicero AFG, Cirillo M, Cirillo P, Dell'Oro R, D'elia L, Desideri G, Ferri C, Galletti F, Gesualdo L, Giannattasio C, Iaccarino G, Lippa L, Mallamaci F, Masi S, Maloberti A, Masulli M, Mazza A, Mengozzi A, Muiesan ML, Nazzaro P, Palatini P, Parati G, Pontremoli R, Quarti-Trevano F, Rattazzi M, Reboldi G, Rivasi G, Salvetti M, Tocci G, Ungar A, Verdecchia P, Viazzi F, Volpe M, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA)., Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values, «JOURNAL OF HYPERTENSION», 2023, 41, pp. 180 - 186 [articolo]Open Access
Mengozzi A, Pugliese NR, Desideri G, Masi S, Angeli F, Barbagallo CM, Bombelli M, Cappelli F, Casiglia E, Cianci R, Ciccarelli M, Cicero AFG, Cirillo M, Cirillo P, Dell'Oro R, D'Elia L, Ferri C, Galletti F, Gesualdo L, Giannattasio C, Grassi G, Iaccarino G, Lippa L, Mallamaci F, Maloberti A, Masulli M, Mazza A, Muiesan ML, Nazzaro P, Palatini P, Parati G, Pontremoli R, Quarti-Trevano F, Rattazzi M, Reboldi G, Rivasi G, Russo E, Salvetti M, Tikhonoff V, Tocci G, Ungar A, Verdecchia P, Viazzi F, Volpe M, Borghi C, Virdis A; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA)., Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study, «METABOLITES», 2023, 13, Article number: 244, pp. 1 - 15 [articolo]Open Access
Fogacci F, Yerlitaş Sİ, Giovannini M, Zararsız G, Lido P, Borghi C, Cicero AFG, Sex X Time Interactions in Lp(a) and LDL-C Response to Evolocumab, «BIOMEDICINES», 2023, 11, Article number: 3271, pp. 1 - 11 [articolo]Open Access
Cicero AFG, Fogacci F, Bragagni A, Borghi C., Short-term evolocumab-induced tendon xanthomas regression in an elderly patient with homozygous familial hypercholesterolemia, «INTERNAL AND EMERGENCY MEDICINE», 2023, 18, pp. 307 - 310 [articolo]Open Access
Minuz P, Albini FL, Imbalzano E, Izzo R, Masi S, Pengo MF, Pucci G, Scalise F, Salvetti M, Tocci G, Cicero A, Iaccarino G, Savoia C, Sechi L, Parati G, Borghi C, Volpe M, Ferri C, Grassi G, Muiesan ML; Italian Society of Arterial Hypertension (SIIA)., Telemedicine and Digital Medicine in the Clinical Management of Hypertension and Hypertension-Related Cardiovascular Diseases: A Position Paper of the Italian Society of Arterial Hypertension (SIIA), «HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION», 2023, 30, pp. 387 - 399 [articolo]Open Access
Cicero, ARRIGO FRANCESCO GIUSEPPE; Fogacci, F; Giovannini, M; Rizzoli, E; Grandi, E; D'Addato, S; Borghi, C., The Effect of Dietary Supplementation with Plant Sterols on Total and LDL-Cholesterol in Plasma Is Affected by Adherence to Mediterranean Diet: Insights from the DESCO Randomized Clinical Study, «NUTRIENTS», 2023, 15, Article number: 4555, pp. 1 - 13 [articolo]Open Access
Colletti A, Pellizzato M, Cicero AF., The Possible Role of Probiotic Supplementation in Inflammation: A Narrative Review, «MICROORGANISMS», 2023, 11, Article number: 2160, pp. 1 - 18 [articolo]Open Access
Maloberti A, Mengozzi A, Russo E, Cicero AFG, Angeli F, Agabiti Rosei E, Barbagallo CM, Bernardino B, Bombelli M, Cappelli F, Casiglia E, Cianci R, Ciccarelli M, Cirillo M, Cirillo P, Desideri G, D'Elia L, Dell'Oro R, Facchetti R, Ferri C, Galletti F, Giannattasio C, Gesualdo L, Iaccarino G, Lippa L, Mallamaci F, Masi S, Masulli M, Mazza A, Muiesan ML, Nazzaro P, Parati G, Palatini P, Pauletto P, Pontremoli R, Pugliese NR, Quarti-Trevano F, Rattazzi M, Reboldi G, Rivasi G, Salvetti M, Tikhonoff V, Tocci G, Ungar A, Verdecchia P, Viazzi F, Volpe M, Virdis A, Grassi G, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA)., The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation., «HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION», 2023, 30, pp. 411 - 425 [articolo]Open Access
Bielecka-Dabrowa A, Banach M, Wittczak A, Cicero AFG, Kallel A, Kubilius R, Mikhailidis DP, Sahebkar A, Pantea Stoian A, Vinereanu D, Penson PE, von Haehling S., The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper, «ARCHIVES OF MEDICAL SCIENCE», 2023, 19, pp. 841 - 864 [articolo]Open Access
Fogacci F, Borghi C, Cicero AFG, The short-circuit evidence on lipid-lowering drugs use in pregnancy, «ATHEROSCLEROSIS», 2023, 368, pp. 12 - 13 [nota a sentenza]
